Summary
NIBEA will turn the developments and understanding from NANOIMPACTS into real world analytical practice such that reliable analytical protocols are established, validated and demonstrated especially in the context of real world media (environmental, industrial, medical) providing an entirely new approach to nanoparticle analysis based on electrochemical measurements.
NIBEA will provide a step change in comparison with the present state of the art since particles of much smaller size and of greater diversity (including bacteria, viruses) deriving from authentic media with zero or minimal pre-treatment will be detected in the solution phase.
NIBEA will develop prototype instrumentation suitable for demonstration purposes covering both batch and on-line nanoparticle analyses. It will also establish and validate against independent methods methodology for the analysis (identity, size, concentration, state of aggregation/agglomeration) of (a) silver nanoparticles in water and waste systems and (b) viruses and bacteria of biomedical importance
NIBEA will have major societal impact in furthering studies of toxicology, facilitating environmental, medical and at point-of-discharge analysis, as well as facilitating the application of expected forthcoming legislation on nanoparticles. Subsequently we aim to commercialise the IP building on the track record of the Compton Group (sensing of pH, gases, garlic, chilli heat, etc) and with the assistance of Oxford Innovation Ltd (http://www.oxin.co.uk/) specialists in university KT.
NIBEA will provide a step change in comparison with the present state of the art since particles of much smaller size and of greater diversity (including bacteria, viruses) deriving from authentic media with zero or minimal pre-treatment will be detected in the solution phase.
NIBEA will develop prototype instrumentation suitable for demonstration purposes covering both batch and on-line nanoparticle analyses. It will also establish and validate against independent methods methodology for the analysis (identity, size, concentration, state of aggregation/agglomeration) of (a) silver nanoparticles in water and waste systems and (b) viruses and bacteria of biomedical importance
NIBEA will have major societal impact in furthering studies of toxicology, facilitating environmental, medical and at point-of-discharge analysis, as well as facilitating the application of expected forthcoming legislation on nanoparticles. Subsequently we aim to commercialise the IP building on the track record of the Compton Group (sensing of pH, gases, garlic, chilli heat, etc) and with the assistance of Oxford Innovation Ltd (http://www.oxin.co.uk/) specialists in university KT.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/727292 |
| Start date: | 01-05-2017 |
| End date: | 31-10-2018 |
| Total budget - Public funding: | 149 989,00 Euro - 149 989,00 Euro |
Cordis data
Original description
NIBEA will turn the developments and understanding from NANOIMPACTS into real world analytical practice such that reliable analytical protocols are established, validated and demonstrated especially in the context of real world media (environmental, industrial, medical) providing an entirely new approach to nanoparticle analysis based on electrochemical measurements.NIBEA will provide a step change in comparison with the present state of the art since particles of much smaller size and of greater diversity (including bacteria, viruses) deriving from authentic media with zero or minimal pre-treatment will be detected in the solution phase.
NIBEA will develop prototype instrumentation suitable for demonstration purposes covering both batch and on-line nanoparticle analyses. It will also establish and validate against independent methods methodology for the analysis (identity, size, concentration, state of aggregation/agglomeration) of (a) silver nanoparticles in water and waste systems and (b) viruses and bacteria of biomedical importance
NIBEA will have major societal impact in furthering studies of toxicology, facilitating environmental, medical and at point-of-discharge analysis, as well as facilitating the application of expected forthcoming legislation on nanoparticles. Subsequently we aim to commercialise the IP building on the track record of the Compton Group (sensing of pH, gases, garlic, chilli heat, etc) and with the assistance of Oxford Innovation Ltd (http://www.oxin.co.uk/) specialists in university KT.
Status
CLOSEDCall topic
ERC-PoC-2016Update Date
27-04-2024
Images
No images available.
Geographical location(s)
